Ganoderma applanatum is one of the most popular medicinal mushrooms due to the various biologically active components it produces. In order to study for the possibility of artificially cultivating G. applanatum, we investigated the growth status of G. applanatum mycelium using oak sawdust bottle(850 ml). It took approximately 17~27 days for G. applanatum cultivation and 15~16 days for G. lucidum cultivation with sawdust until the mycelial growth was complete. The weight of dried fruiting bodies showed that G. applanatum GBGA-01 weighed 16.0±7.4 g, and G. lucidum ASI 7125 weighed 7.9±2.7g. The thickness of the pileus was measured as 10.6±2.6 mm for G. applanatum GBGA-01, 16.3±8.7 mm for G. applanatum ASI 52823 and 8.6±3.5 mm for G. lucidum ASI 7125. The color of Ganoderma spp. showed that L degree was 55.5±1.1 for the contex of G. applanatum GBGA-01, 47.7±2.2 for the contex of G. applanatum ASI 52823 and 39.6±2.9 for the contex of G. lucidum ASI 7125.

한약재로 사용되는 더덕과 도라지에 표고의 유용성분을 함유한 소재를 개발하고자 더덕표고균사발효물(FCLM)과 더덕도라지균사발효물(FPLM)을 제조하였다. 두 가지 발효물의 일반성분, 유리당, 유기산, β-glucan, ergothioneine, ergosterol, vitamin D2 함량 및 3T3-L1 지방전구세포의 분화에 미치는 영향을 연구하였다. 일반성분 분석결과, FCLM에서 조섬유와 조지방함량이 FPLM에 비하여 높게 나타났으며, FPLM은 조단백질과 가용성무질소물의 함량 이 FCLM에 비하여 높게 나타났다. 유리당은 FCLM과 FPLM 모두 arabinose, glucose, sucrose 3종이 검출되었으며, 총 유리당 함량은 FPLM에서 높게 나타났다. 유기 산 함량은 발효 전 더덕과 도라지에 비하여 발효 후 FCLM과 FPLM에서 낮게 나타났다. β-Glucan 함량은 FCLM과 FPLM 두 발효물에서 대조구로 사용한 표고보다 높은 함량을 보였다. 항산화 물질로 알려진 ergothioneine의 함량은 FCLM이 FPLM보다 높게 나타났다. Ergosterol 함량은 대조구로 사용한 표고에서 가장 높게 나타났으며, 발효물들은 비슷한 함량을 나타내었다. Vitamin D2는 발효물들에서만 검출되었으며, FPLM (0.58±0.01 mg%)가 FCLM (0.47±0.01 mg%)보다 높은 함량을 보였다. 더덕과 도라지 표고균사발효물인 FCLM과 FPLM는 3T3-L1 지방전구세포에 대하여 발효 전 더덕과 도라지에 비하여 높은 수준의 세포 생존율을 나타내었다. 또한 FCLM과 FPLM은 3T3-L1 지방전구세포 분화를 발효 전 더덕과 도라지에 비하여 높은 수준으로 억제하여, 비만 억제 효과 가 있는 것으로 기대된다.

Anti-melanogenesis and skin anti-wrinkle effects of methanol (ME) and hot water (HE) extracts from the fruiting bodies of Ganoderma applanatum were investigated in this study. The total phenolic contents of the ME and HE of the mushroom were 11.68 and 3.15 μg GAEs/mg, respectively, whereas the total flavonoid contents of the ME and HE were 21.82 and 2.69 μg QEs/mg, respectively. The survival rate of B16-F10 murine melanoma cells treated with 750 μg ME and HE were 83.46% and 85.54%, respectively, thereby suggesting that mushroom extracts were slightly cytotoxic at the tested concentration. The in vitro tyrosinase inhibition by ME (83.15%) and HE (83.44%) was significantly lower than that of kojic acid (99.61%), the positive control, at 2.0 mg/mL. Although the inhibition of cellular melanin synthesis in B16-F10 melanoma cells by 2.0 mg/mL of ME (50.24%) and HE (51.24%) was lower than that of arbutin (64.84%), the inhibition by both ME and HE was higher than 50%. Collagenase inhibition by HE was comparable to 2.0 mg/mL epigallocatechin (EGCG), the positive control; however, elastase inhibition by ME and HE was lower than that of EGCG at the concentration tested. The results showed that the fruiting bodies of G. applanatum had good anti-tyrosinase, good anti-collagenase, and moderate anti-elastase activities, which might be useful for developing novel skin-whitening and anti-wrinkle agents.

To concern about health increased at well-being world. It reported fault about toxic of lymphocyte cell by Chemotherapeutic agent and antibiotic agent, tolerance of cancer cell and destruction of lymphocyte and marrow cell. Study of natural medicine needed to remedy these shortcomings. In this study verified effect of anti-inflammatory and antioxidant in Ganoderma applanatum. Verify of anti-inflammatory effect checked to derive by LPS. Antioxidant effect assured by DPPH radical scavenging activity and superoxide dismutase (SOD) activity. The result of cytotoxicity by MTT-assay for anti-inflammatory effect of Ganoderma applanatum does not effect in 0.01~1mg/mL concentration. Nitric oxide (NO) inhibition effect was verified concentration dependent in all treatment groups. Inflammatory cytokine (TNF-α,IL-1β,IL-6) formation inhibition effect to derive by LPS was verified to inhibit gene revelation of inflammatory cytokine in all treatment groups. And endotoxin shock inhibition effect does not appear concentration dependent in mouse lethal test. Inflammation mediator activation inhibition effect in shock mouse liver cell decreased gene revelation in IL-1β and IL-6 at 0.5g/kg body weight group and 1.0g/kg body weight group. DPPH radical scavenging activity confirmed concentration dependent in all treatmen tgroups. SOD enzyme activity showed high activity in low concentration than vitamin C and BHT. To conclusion, Ganoderma applanatum was predicted to replace anti-inflammatory medicine and to use great antioxidant material.

Anti-diabetic activities of cultured mycelia from Ganoderma applanatum are being evaluated in this study. The OGTT and 4-weeks of repeated oral efficacy tests are conducted in mice at the doses of 0 (vehicle treatment), 25, 75 and 225 ㎎/㎏/day, respectively. In human study, the test article was administered orally every day for 8-week at a dose of 1,500 ㎎/㎏, tid and placebo group. The blood glucose levels (BGL) at 0.5 hour after treatment are significant decreased in all treatment groups of OGTT test. In the 4-week test, BGL of 75 and 225 ㎎/㎏/day group is continuously decreased during all treatment periods and the BGL of 25 ㎎/㎏/day group show decreasing trends at the final week, the pancreas weight of all treatment groups are being increased, and the Langerhans-islet numbers were increased at all treatment groups with a dose-response manner. There are no test article-related abnormal signs and the fasted blood glucose (FBG), postprandial blood glucose (PPG) and HbA1c are decreased significantly after 8-week treatments. These results that the cultured mycelia from Ganoderma applanatum could decrease BGL by protecting the degeneration of Langerhans islets.